Hemoglobin A1c and Cardiovascular Outcomes Following Percutaneous Coronary Intervention Insights From a Large Single-Center Registry

被引:25
作者
Baber, Usman [1 ,2 ]
Azzalini, Lorenzo [1 ,3 ]
Masoomi, Reza [1 ]
Johal, Gurpreet [1 ]
Barman, Nitin [1 ]
Sweeny, Joseph [1 ]
Krishnan, Prakash [1 ]
Dangas, George [1 ]
Vijay, Pooja [1 ]
Jahveri, Vaishvi B. [1 ]
Mehran, Roxana [1 ]
Fuster, Valentin [1 ,4 ]
Kini, Annapoorna S. [1 ]
Sharma, Samin K. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Virginia Commonwealth Univ, Div Cardiol, VCU Hlth Pauley Heart Ctr, Richmond, VA USA
[4] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain
关键词
diabetes mellitus; hemoglobin A(1c); percutaneous coronary intervention; DIABETIC-PATIENTS; GLYCEMIC CONTROL; MORTALITY; HYPERGLYCEMIA; ASSOCIATION; MELLITUS; RISK; A1C;
D O I
10.1016/j.jcin.2020.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to evaluate post-percutaneous coronary intervention (PCI) outcomes in relation to pre-procedural glycated hemoglobin (HbA(1c)) levels from a large, contemporary cohort. BACKGROUND There are limited data evaluating associations between HbA(1c), a marker of glycemic control, and ischemic risk following PCI. METHODS All patients with known HbA(1c) levels undergoing PCI at a single institution between 2009 and 2017 were included. Patients were divided into 5 groups on the basis of HbA(1c) level: <= 5.5%, 5.6% to 6.0%, 6.1% to 7.0%, 7.1% to 8.0%, and >8.0%. The primary endpoint was major adverse cardiac events (MACE), a composite of all-cause death or myocardial infarction (MI), at 1-year follow-up. RESULTS A total of 13,543 patients were included (HbA(1c) <= 5.5%, n = 1,214; HbA(1c) 5.6% to 6.0%, n = 2,202; HbA(1c) 6.1% to 7.0%, n = 4,130; HbA(1c) 7.1% to 8.0%, n = 2,609; HbA(1c) >8.0%, n = 3,388). Patients with both low (HbA(1c) <= 5.5%) and high (HbA(1c) >8.0%) levels displayed an increased risk for MACE compared with those with values between 6.1% and 7.0%. Excess risk was driven primarily by higher rates of all-cause death among those with low HbA(1c) levels, while higher values were strongly associated with greater MI risk. Patterns of risk were unchanged among patients with serial HbA(1c) levels and persisted after multivariate adjustment. CONCLUSIONS Among patients undergoing PCI, pre-procedural HbA(1c) levels display a U-shaped association with 1-year MACE risk, a pattern that reflects greater risk for death in the presence of low HbA(1c) (<= 5.5%) and higher risk for MI with higher values (>8.0%). (C) 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation.
引用
收藏
页码:388 / 397
页数:10
相关论文
共 18 条
[1]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc14-S081, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc13-S011, 10.2337/dc11-S062, 10.2337/dc11-S011, 10.2337/dc10-S062, 10.2337/dc12-s011, 10.2337/dc12-s064]
[2]   Acute hyperglycemia and oxidative stress: Direct cause and effect? [J].
Choi, Siu-Wai ;
Benzie, Iris F. F. ;
Ma, Shuk-Woon ;
Strain, J. J. ;
Hannigan, Bernadette M. .
FREE RADICAL BIOLOGY AND MEDICINE, 2008, 44 (07) :1217-1231
[3]   Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention [J].
Corpus, RA ;
George, PB ;
House, JA ;
Dixon, SR ;
Ajluni, SC ;
Devlin, WH ;
Timmis, GC ;
Balasubramaniam, M ;
O'Neill, WW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) :8-14
[4]   Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study [J].
Currie, Craig J. ;
Peters, John R. ;
Tynan, Aodan ;
Evans, Marc ;
Heine, Robert J. ;
Bracco, Oswaldo L. ;
Zagar, Tony ;
Poole, Chris D. .
LANCET, 2010, 375 (9713) :481-489
[5]   Prognostic Impact of Hyperglycemia in Nondiabetic and Diabetic Patients With ST-Elevation Myocardial Infarction Insights From Contrast-Enhanced Magnetic Resonance Imaging [J].
Eitel, Ingo ;
Hintze, Stefan ;
de Waha, Suzanne ;
Fuernau, Georg ;
Lurz, Philipp ;
Desch, Steffen ;
Schuler, Gerhard ;
Thiele, Holger .
CIRCULATION-CARDIOVASCULAR IMAGING, 2012, 5 (06) :708-718
[6]   U-Shape Association Between Hemoglobin A1c and Late Mortality in Patients With Heart Failure After Cardiac Surgery [J].
Engoren, Milo ;
Schwann, Thomas A. ;
Arslanian-Engoren, Cynthia ;
Maile, Michael ;
Habib, Robert H. .
AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (08) :1209-1213
[7]   Standardized End Point Definitions for Coronary Intervention Trials [J].
Garcia-Garcia, Hector M. ;
McFadden, Eugene P. ;
Farb, Andrew ;
Mehran, Roxana ;
Stone, Gregg W. ;
Spertus, John ;
Onuma, Yoshinobu ;
Morel, Marie-angele ;
van Es, Gerrit-Anne ;
Zuckerman, Bram ;
Fearon, William F. ;
Taggart, David ;
Kappetein, Arie-Pieter ;
Krucoff, Mitchell W. ;
Vranckx, Pascal ;
Windecker, Stephan ;
Cutlip, Donald ;
Serruys, Patrick W. .
EUROPEAN HEART JOURNAL, 2018, 39 (23) :2192-2207
[8]  
Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
[9]   Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis [J].
Gorst, Catherine ;
Kwok, Chun Shing ;
Aslam, Saadia ;
Buchan, Iain ;
Kontopantelis, Evangelos ;
Myint, Phyo K. ;
Heatlie, Grant ;
Loke, Yoon ;
Rutter, Martin K. ;
Mamas, Mamas A. .
DIABETES CARE, 2015, 38 (12) :2354-2369
[10]   Glycemic Control, Complications, and Death in Older Diabetic Patients The Diabetes and Aging Study [J].
Huang, Elbert S. ;
Liu, Jennifer Y. ;
Moffet, Howard H. ;
John, Priya M. ;
Karter, Andrew J. .
DIABETES CARE, 2011, 34 (06) :1329-1336